Transradial versus transfemoral intervention in non-ST-segment elevation acute coronary syndrome patients undergoing percutaneous coronary intervention: the Korean transradial intervention registry of 1 285 patients
- Authors
- Lee, Min-Ho; Bang, Duk Won; Park, Byung Won; Cho, Byung-Ryul; Rha, Seung-Woon; Jeong, Myung Ho; Yoon, Junghan; Suh, Jon; Han, Kyoo-Rok; Hyon, Min Su
- Issue Date
- 11월-2018
- Publisher
- CLINICS CARDIVE PUBL PTY LTD
- Keywords
- radial artery; femoral artery; acute coronary syndrome; myocardial infarction; percutaneous coronary intervention
- Citation
- CARDIOVASCULAR JOURNAL OF AFRICA, v.29, no.6, pp.374 - 380
- Indexed
- SCIE
SCOPUS
- Journal Title
- CARDIOVASCULAR JOURNAL OF AFRICA
- Volume
- 29
- Number
- 6
- Start Page
- 374
- End Page
- 380
- URI
- https://scholar.korea.ac.kr/handle/2021.sw.korea/71999
- DOI
- 10.5830/CVJA-2018-047
- ISSN
- 1995-1892
- Abstract
- Introduction: Although the implementation of transradial intervention (TRI) has increased over the last few years. there are limited data on the impact of TRI on efficacy and safety in patients with non-ST-segment elevation acute coronary syndrome (NSTE-ACS). We sought to compare one-year clinical outcomes and bleeding complications of TRI with those of transfemoral intervention (TFI) in patients with NSTE-ACS. Methods: The Korean TRI registry was a cohort of 20 centres from 2012 to 2015. The primary efficacy endpoint was major adverse cardiovascular events (MACE), defined as a composite of cardiac death (CD), non-fatal myocardial infarction (MI) and repeat revascularisation (RR). Among the 1 319 patients with NSTE-ACS, 1 285 were finally it analysed after excluding 34 due to lack of follow-up data. The patients were divided into TRI and TEI groups according to the final access site. Results: At one-year follow up, the TRI group showed a significantly lower rate of MACE, and a marginally significantly lower rate of CD than the TFI group in the crude population. However. in propensity-score matched analysis, the rate of MACE did not differ between the TRI and TFI groups. Regarding bleeding complications, the TRI group was associated with significantly lower rates of major bleeding in both the crude and matched populations. Independent predictors of MACE were chronic kidney disease (CKD) and multi-vessel disease (MVD). Conclusions: In patients with NSTE-ACS, TRI was associated with favourable one-year clinical outcomes and lower bleeding complications compared to TFI, Independent predictors of MACE were clinical and angiogrziphic profiles (CKD, MVD) rather than vascular access sites.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - Graduate School > Department of Biomedical Sciences > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.